about
The SCN8A encephalopathy mutation p.Ile1327Val displays elevated sensitivity to the anticonvulsant phenytoin.SCN8A mutation in a child presenting with seizures and developmental delaysEpileptic Encephalopathy in Infants and ChildrenDNM1 encephalopathy: A new disease of vesicle fission.Neuronal hyperexcitability in a mouse model of SCN8A epileptic encephalopathy.The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: Channelopathies, synaptopathies, and transportopathies.De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis.Altered gene expression profile in a mouse model of SCN8A encephalopathy.Loss-of-function variants of SCN8A in intellectual disability without seizures.SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizuresCannabidiol Mellows Out Resurgent Sodium CurrentAberrant Sodium Channel Currents and Hyperexcitability of Medial Entorhinal Cortex Neurons in a Mouse Model of SCN8A Encephalopathy.Regulation of Thalamic and Cortical Network Synchrony by Scn8a.De novo variants in the alternative exon 5 of SCN8A cause epileptic encephalopathy.Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy.Differential roles of NaV1.2 and NaV1.6 in regulating neuronal excitability at febrile temperature and distinct contributions to febrile seizures.Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain.Phenytoin as a last-resort treatment in SCN8A encephalopathy.Partial loss-of-function of sodium channel SCN8A in familial isolated myoclonusThe novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy
P2860
Q30276427-81D97C81-581F-478F-90C4-E9075682066FQ30828822-C9DE9E7D-C9F5-49E7-A715-1A2510FF1D06Q37182454-5EDDB312-1021-401B-851C-D34EDA935C69Q38699304-8E231A65-37C2-4B8C-AC12-C43162CB1BEEQ38757993-49514ECB-AD98-487F-9E35-2A77A1A08F4BQ39090098-DCDC1A38-76C1-46E2-84FC-2E91741FED6DQ39163038-80A38D26-10A0-4775-98AA-21C0EBC29D27Q39194220-92782945-C0DB-49FB-8E83-8CE4D2491AAAQ40949618-4E786C71-077C-4C7C-88BF-6154E3EBF3D8Q41704860-5C882A3C-A46F-4BED-BCF1-5D85722870B0Q42369778-02C33698-D982-4C8A-8F60-592812AC0AD4Q45062644-B522DBE0-759D-4573-898F-38CF6941B679Q46070864-C5E80616-F1E7-4372-90FF-6E080585097BQ47625623-CC4F63F3-6F04-4D3C-B705-E555BB737609Q47840577-F59E96F6-4AA8-4527-A8A4-431A0206BCCCQ47863612-758ADDEA-B450-4134-8A38-A054493E3873Q52678220-9897241F-9B7E-4E42-A6B7-B6EAADE5BD44Q54941950-4B8F3974-22AD-4A7F-A17B-CFCF8D870160Q56349519-B2D776E4-6F95-4510-BBF6-BDA15CA9CAA1Q56365819-98464471-AC16-4494-80D1-AE42CF775562
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
SCN8A encephalopathy: Research progress and prospects
@ast
SCN8A encephalopathy: Research progress and prospects
@en
type
label
SCN8A encephalopathy: Research progress and prospects
@ast
SCN8A encephalopathy: Research progress and prospects
@en
prefLabel
SCN8A encephalopathy: Research progress and prospects
@ast
SCN8A encephalopathy: Research progress and prospects
@en
P2093
P2860
P50
P921
P356
P1433
P1476
SCN8A encephalopathy: Research progress and prospects
@en
P2093
Alan L Goldin
Atsushi Ishii
Barbara L Kroner
Brandy E Fureman
Heather C Mefford
Ingrid E Scheffer
Jack M Parent
Jacy L Wagnon
Karen Wilcox
Manoj Patel
P2860
P304
P356
10.1111/EPI.13422
P407
P577
2016-06-08T00:00:00Z